Jeffrey Moore
Director/Board Member bij MP Healthcare Venture Management, Inc.
Profiel
Jeffrey Moore is currently serving as the President of MP Healthcare Venture Management, Inc. and as a Board Member of PharmEnable Therapeutics Ltd., Capsigen, Inc., and SOLA Biosciences LLC.
Previously, he worked as a Director at QurAlis Corp.
from 2018 to 2020.
He also held positions as a Principal at Millennium Pharmaceuticals, Inc., Scriptgen Pharmaceuticals, Inc., and RCT BioVentures.
Additionally, he served as a Board Member at Diamond Edge Ventures, Inc. Dr. Moore received his doctorate from the University of Oxford, his MBA from the Massachusetts Institute of Technology, and his undergraduate degree from the University of New Brunswick.
He also received a graduate degree from Harvard Medical School.
Actieve functies van Jeffrey Moore
Bedrijven | Functie | Begin |
---|---|---|
MP Healthcare Venture Management, Inc.
MP Healthcare Venture Management, Inc. Investment ManagersFinance MP Healthcare Venture Management, Inc (MP Healthcare Venture) is a venture capital subsidiary of Mitsubishi Tanabe Pharma Corp founded in 2006. The firm is headquartered in Boston, Massachusetts. | Director/Board Member | 01-01-2008 |
SOLA Biosciences LLC
SOLA Biosciences LLC Pharmaceuticals: MajorHealth Technology SOLA Biosciences LLC is a pre-clinical-stage biopharmaceutical company that develops gene-therapies for patients with neurodegenerative diseases. The company is based in Natick, MA. The company was founded by Akinori Hishiya, Keizo Koya. Keizo Koya has been the CEO since incorporation. | Director/Board Member | 01-09-2021 |
Capsigen, Inc.
Capsigen, Inc. BiotechnologyHealth Technology Capsigen, Inc. is a company based in Vancouver, WA that is developing the next generation of AAV vectors for gene therapy. The company's end-to-end platform uses customized, diverse libraries and proprietary trade™ technology to identify fully functional vectors that meet disease-specific transduction criteria. Capsigen's fit-for-purpose vectors are designed to deliver the highest level of clinical utility in a rapid and high-throughput manner. The company uses data science and directed evolution to build custom AAV capsids to move patients from hope to cured. John Bial has been the CEO of the company since 2020. | Director/Board Member | 01-12-2020 |
Pharmenable Ltd.
Pharmenable Ltd. Pharmaceuticals: MajorHealth Technology Pharmenable Ltd. operates as a drug discovery company. It designs the next generation of small molecule drugs. The company was founded by Hannah Fiona Sore, Natalia Mateu, Jelena Aleksic, David Spring, and Andreas Bender in June 2016 and is headquartered in Histon, the United Kingdom. | Director/Board Member | 01-11-2022 |
Eerdere bekende functies van Jeffrey Moore
Bedrijven | Functie | Einde |
---|---|---|
QurAlis Corp.
QurAlis Corp. Pharmaceuticals: MajorHealth Technology QurAlis Corp. engages in discovering and developing new therapies for amyotrophic lateral sclerosis and other neurological diseases. It offers therapeutic programs and targets, and biomarkers. The company was founded by Clifford Woolf, Kevin Eggan, Jonathan J. Fleming, and Kasper Roet and is headquartered in North Cambridge, MA. | Director/Board Member | 01-04-2020 |
Diamond Edge Ventures, Inc.
Diamond Edge Ventures, Inc. Investment ManagersFinance Diamond Edge Ventures, Inc (Diamond Edge ventures) is a venture capital subsidiary of Mitsubishi Chemical Holdings Corp founded in 2018. The firm is headquartered in San Francisco, California. | Director/Board Member | - |
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | - |
Scriptgen Pharmaceuticals, Inc.
Scriptgen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Scriptgen Pharmaceuticals, Inc. discovers and develops small molecule drugs. It develops antifungal and antibacterial drugs, as well as compounds for treatment of hepatitis. The company is headquartered in Medford, MA | Corporate Officer/Principal | - |
RCT BioVentures
RCT BioVentures Investment ManagersFinance RCT BioVentures (RCT BioVentures) is a venture capital subsidiary of Research Corporation Technologies Inc founded in 1987. The firm is headquartered in Tucson, Arizona. | Corporate Officer/Principal | - |
Opleiding van Jeffrey Moore
University of Oxford | Doctorate Degree |
Massachusetts Institute of Technology | Masters Business Admin |
University of New Brunswick | Undergraduate Degree |
Harvard Medical School | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Bedrijven in privébezit | 9 |
---|---|
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Health Technology |
Scriptgen Pharmaceuticals, Inc.
Scriptgen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Scriptgen Pharmaceuticals, Inc. discovers and develops small molecule drugs. It develops antifungal and antibacterial drugs, as well as compounds for treatment of hepatitis. The company is headquartered in Medford, MA | Health Technology |
RCT BioVentures
RCT BioVentures Investment ManagersFinance RCT BioVentures (RCT BioVentures) is a venture capital subsidiary of Research Corporation Technologies Inc founded in 1987. The firm is headquartered in Tucson, Arizona. | Finance |
MP Healthcare Venture Management, Inc.
MP Healthcare Venture Management, Inc. Investment ManagersFinance MP Healthcare Venture Management, Inc (MP Healthcare Venture) is a venture capital subsidiary of Mitsubishi Tanabe Pharma Corp founded in 2006. The firm is headquartered in Boston, Massachusetts. | Finance |
QurAlis Corp.
QurAlis Corp. Pharmaceuticals: MajorHealth Technology QurAlis Corp. engages in discovering and developing new therapies for amyotrophic lateral sclerosis and other neurological diseases. It offers therapeutic programs and targets, and biomarkers. The company was founded by Clifford Woolf, Kevin Eggan, Jonathan J. Fleming, and Kasper Roet and is headquartered in North Cambridge, MA. | Health Technology |
Diamond Edge Ventures, Inc.
Diamond Edge Ventures, Inc. Investment ManagersFinance Diamond Edge Ventures, Inc (Diamond Edge ventures) is a venture capital subsidiary of Mitsubishi Chemical Holdings Corp founded in 2018. The firm is headquartered in San Francisco, California. | Finance |
Pharmenable Ltd.
Pharmenable Ltd. Pharmaceuticals: MajorHealth Technology Pharmenable Ltd. operates as a drug discovery company. It designs the next generation of small molecule drugs. The company was founded by Hannah Fiona Sore, Natalia Mateu, Jelena Aleksic, David Spring, and Andreas Bender in June 2016 and is headquartered in Histon, the United Kingdom. | Health Technology |
Capsigen, Inc.
Capsigen, Inc. BiotechnologyHealth Technology Capsigen, Inc. is a company based in Vancouver, WA that is developing the next generation of AAV vectors for gene therapy. The company's end-to-end platform uses customized, diverse libraries and proprietary trade™ technology to identify fully functional vectors that meet disease-specific transduction criteria. Capsigen's fit-for-purpose vectors are designed to deliver the highest level of clinical utility in a rapid and high-throughput manner. The company uses data science and directed evolution to build custom AAV capsids to move patients from hope to cured. John Bial has been the CEO of the company since 2020. | Health Technology |
SOLA Biosciences LLC
SOLA Biosciences LLC Pharmaceuticals: MajorHealth Technology SOLA Biosciences LLC is a pre-clinical-stage biopharmaceutical company that develops gene-therapies for patients with neurodegenerative diseases. The company is based in Natick, MA. The company was founded by Akinori Hishiya, Keizo Koya. Keizo Koya has been the CEO since incorporation. | Health Technology |